These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 13485458)

  • 1. [Diabetogenic activity of alloxan in acute hypoxia].
    BOZOVIC L; RABADIJA L; FISTER V
    Rad Med Fak Zagrebu; 1957; 1():65-8. PubMed ID: 13485458
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quantitative evaluation of the sensitivity of experimental animals to the diabetogenic effect of alloxan].
    Pal'chikova NA; Seliatitskaia VG; Shorin IuP
    Probl Endokrinol (Mosk); 1987; 33(4):65-8. PubMed ID: 3658953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental analysis of the pathophysiological significance of the "diabetogenic factor" present in the blood of animals with alloxan diabetes].
    Baskakova GM; Kudriashov BA; Pytel' IuA
    Probl Endokrinol (Mosk); 1981; 27(4):42-5. PubMed ID: 7027248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of cats to the diabetogenic effect of alloxan.
    Hatchell DL; Reiser HJ; Bresnahan JF; Whitworth UG
    Lab Anim Sci; 1986 Feb; 36(1):37-40. PubMed ID: 3959532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intensification of the diabetogenic effect of alloxan by protamine sulfate].
    Kudriashov BA; Ul'ianov AM; Tarasov IuA
    Vopr Med Khim; 1989; 35(4):128-31. PubMed ID: 2815670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of cobalt chloride on experimental diabetes produced by alloxan and by pancreatic diabetogenic factor].
    AVEZZU G
    Arch Maragliano Patol Clin; 1952; 7(5):837-49. PubMed ID: 13017834
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diabetogenic action of alloxan in short-term termination of the blood supply to the pancreas and spleen].
    Ul'ianov AM; Tarasov IuA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1984; (8):48-51. PubMed ID: 6487685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kidney and alloxan diabetes; influence of prior uranium intoxication on the action of non-diabetogenic doses of alloxan].
    ARTETA JL; GIL JD
    Acta Endocrinol Iber; 1951; 1(3):164-72. PubMed ID: 14932727
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antianemic effect of reamberin in rats with acute alloxan-induced diabetes].
    Volchegorskiĭ IA; Tishevskaia NV; Dement'eva EV
    Eksp Klin Farmakol; 2008; 71(6):23-7. PubMed ID: 19140511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The resistance of the young rabbit to the diabetogenic effect of alloxan.
    SHULTZ CS; DUKE JR
    Bull Johns Hopkins Hosp; 1948 Jan; 82(1):20-41. PubMed ID: 18920019
    [No Abstract]   [Full Text] [Related]  

  • 11. Modification of the diabetogenic action of alloxan by epinephrine, and the possibility of nonspecific protection in experimental diabetes.
    VOLLMER EP; GOLDEN R; DIXON W
    Memo Rep Nav Med Res Inst (US); 1960 Jul; 00001():173-81. PubMed ID: 13831341
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of pH on the diabetogenic action of alloxan.
    KLEBANOFF SJ; GREENBAUM AL
    J Endocrinol; 1954 Nov; 11(4):314-22. PubMed ID: 13211890
    [No Abstract]   [Full Text] [Related]  

  • 13. [The pancreas as a source of natural diabetogenic factor in alloxan diabetes].
    Kudriashov BA; Tarasov IuA; Ul'ianov AM
    Patol Fiziol Eksp Ter; 1991; (2):46-7. PubMed ID: 1881712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of the protective effects of adrenaline upon the diabetogenic action of alloxan in the dog.
    ARTETA JL; CARBALLIDO A
    J Endocrinol; 1956 Nov; 14(3):234-9. PubMed ID: 13376832
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of a previous injection of epinephrine upon the diabetogenic effect of alloxan in rabbits.
    CARRASCO-FORMIGUERA R; ESCOBAR I
    Am J Physiol; 1948 Mar; 152(3):609-14. PubMed ID: 18863163
    [No Abstract]   [Full Text] [Related]  

  • 16. The preventive effect of glucagon (HGF) against the diabetogenic action of alloxan and its antagonism by insulin.
    ARTETA JL; CARBALLIDO A
    J Endocrinol; 1957 Jul; 15(3):243-7. PubMed ID: 13463225
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of diabetogenic effect of alloxan by preceding administration of glucose].
    MASKE H; WOLFF H; STAMPFL B
    Klin Wochenschr; 1953 Jan; 31(3-4):79-81. PubMed ID: 13062577
    [No Abstract]   [Full Text] [Related]  

  • 18. The diabetogenic effect of alloxan after elimination of extra-pancreatic factors.
    HELLMAN B; DIDERHOLM H
    Acta Endocrinol (Copenh); 1955 Sep; 20(1):81-7. PubMed ID: 13275237
    [No Abstract]   [Full Text] [Related]  

  • 19. The prevention of alloxan-induced diabetes by the immunosuppressive agent azathioprine.
    Heikkila RE; Cabbat FS
    Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):163-71. PubMed ID: 7196067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against diabetogenic action of alloxan.
    JANES RG; SCHUELER FW
    Proc Soc Exp Biol Med; 1955 Aug; 89(4):582-4. PubMed ID: 13254832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.